Technological adoption is accelerating as industries move away from traditional thermal and chemical processes. Cold plasma, which allows for low-temperature surface treatment, cleaning, and sterilization, has become a preferred method for handling heat-sensitive components. The medical sector is currently leading this transition, with specialized wound-healing applications and infection control protocols expected to register the highest growth rates over the next five years.
Cold Plasma Market Projected to Hit $3.03 Billion by 2031
The global cold plasma market is set for steady expansion, with valuations expected to climb from $2.15 billion in 2026 to $3.03 billion by 2031. Driven by a 7.1% compound annual growth rate, the sector is increasingly shifting toward automated, chemical-free solutions across medical and industrial manufacturing.
Market dynamics are characterized by a move toward integrated systems rather than standalone hardware. Atmospheric-pressure technology, which accounted for over 63% of the market in 2025, continues to dominate due to its scalability and the elimination of vacuum chamber requirements. Geographically, the Asia-Pacific region is emerging as a primary growth engine, fueled by rapid industrialization and significant investments in semiconductor and healthcare infrastructure. Consolidation remains a defining feature of the landscape, with top-tier players like Nordson Corporation, Bodycote, and Mycronic holding nearly 86% of the market share as they pursue strategic acquisitions to bolster their technical capabilities.
Comments (0)
No comments yet. Be the first!